Abstract |
This study aimed to investigate the efficacy of the etonogestrel (ENG)-releasing implant in treating patients with rectovaginal endometriosis. The study was based on the retrospective analysis of a prospectively collected database, including symptomatic women who had ultrasonographic diagnosis of rectovaginal endometriosis. Patients were follow-up at 6, 12 and 24 months from the insertion of the ENG-releasing implant. The intensity of pain symptoms was evaluated using a visual analog scale. The volume of the nodules was estimated by virtual organ computer-aided analysis. The Endometriosis Health Profile (EHP-30) was used to evaluate quality of life. Overall, 43 women were included in the study. The 2-year continuation rate for the ENG-releasing implant was 93.0%. The treatment quickly improved the intensity of non-menstrual pelvic pain, deep dyspareunia, dysmenorrhea, and dyschezia. At 6-month follow-up, there were improvements in all domains of the EHP-30 compared with baseline. Further improvements in the EHP-30 results were observed only in pain sub score at 12-month follow-up and in emotional well-being sub score at 24-month follow-up. At 6-month follow-up the volume of the rectovaginal nodules was significantly lower compared with baseline; a further decrease was observed at 12- and 24-month follow-up. The treatment was well tolerated.
|
Authors | Simone Ferrero, Carolina Scala, Stefano Ciccarelli, Valerio Gaetano Vellone, Fabio Barra |
Journal | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
(Gynecol Endocrinol)
Vol. 36
Issue 6
Pg. 540-544
(Jun 2020)
ISSN: 1473-0766 [Electronic] England |
PMID | 31711348
(Publication Type: Journal Article)
|
Chemical References |
- Contraceptive Agents, Female
- Contraceptive Agents, Hormonal
- Drug Implants
- etonogestrel
- Desogestrel
|
Topics |
- Adult
- Contraceptive Agents, Female
(administration & dosage, adverse effects)
- Contraceptive Agents, Hormonal
(administration & dosage, adverse effects)
- Desogestrel
(administration & dosage, adverse effects)
- Drug Implants
- Dysmenorrhea
(drug therapy)
- Dyspareunia
(drug therapy)
- Endometriosis
(drug therapy)
- Female
- Follow-Up Studies
- Humans
- Italy
- Pain Measurement
- Pelvic Pain
(drug therapy)
- Quality of Life
- Rectal Diseases
(drug therapy)
- Retrospective Studies
- Treatment Outcome
- Vaginal Diseases
(drug therapy)
|